论文标题
深度学习系统到筛查冠状病毒疾病2019肺炎
Deep Learning System to Screen Coronavirus Disease 2019 Pneumonia
论文作者
论文摘要
我们发现,实时逆转录聚合酶链反应(RT-PCR)检测来自痰液或鼻咽拭子的病毒RNA在早期阶段的正速率相对较低,以确定COVID-19(由世界卫生组织命名)。 COVID-19的计算机断层扫描(CT)成像的表现具有其自身的特征,这些特征与其他类型的病毒性肺炎不同,例如流感-A病毒性肺炎。因此,临床医生呼吁尽快针对这种新型肺炎的另一项早期诊断标准。这项研究旨在建立一种早期筛查模型,以使用深度学习技术来区分Covid-19-19-19-19-a-A-A-A-A-A-a病毒性肺炎,并使用肺部CT图像进行肺部CT图像。首先,使用肺CT图像集的3维深度学习模型将候选感染区域分割。然后将这些分离的图像分为COVID-19,流感 - A流行性肺炎,与感染组无关,以及使用位置注意分类模型的相应置信度分数。最后,该CT病例的感染类型和总置信度得分是通过嘈杂或贝叶斯功能计算的。基准数据集的实验结果表明,从整个CT病例的角度来看,总体精度为86.7%。这项研究中建立的深度学习模型有效地筛选了CoVID 19患者的早期诊断,并证明了前所未有的诊断方法。
We found that the real time reverse transcription-polymerase chain reaction (RT-PCR) detection of viral RNA from sputum or nasopharyngeal swab has a relatively low positive rate in the early stage to determine COVID-19 (named by the World Health Organization). The manifestations of computed tomography (CT) imaging of COVID-19 had their own characteristics, which are different from other types of viral pneumonia, such as Influenza-A viral pneumonia. Therefore, clinical doctors call for another early diagnostic criteria for this new type of pneumonia as soon as possible.This study aimed to establish an early screening model to distinguish COVID-19 pneumonia from Influenza-A viral pneumonia and healthy cases with pulmonary CT images using deep learning techniques. The candidate infection regions were first segmented out using a 3-dimensional deep learning model from pulmonary CT image set. These separated images were then categorized into COVID-19, Influenza-A viral pneumonia and irrelevant to infection groups, together with the corresponding confidence scores using a location-attention classification model. Finally the infection type and total confidence score of this CT case were calculated with Noisy-or Bayesian function.The experiments result of benchmark dataset showed that the overall accuracy was 86.7 % from the perspective of CT cases as a whole.The deep learning models established in this study were effective for the early screening of COVID-19 patients and demonstrated to be a promising supplementary diagnostic method for frontline clinical doctors.